Detailed Information on Publication Record
2022
Reply to Chen et al.
FILA, Petr, Jan GOFUS, Petr NĚMEC and Jan VOJACEKBasic information
Original name
Reply to Chen et al.
Authors
FILA, Petr (203 Czech Republic, guarantor, belonging to the institution), Jan GOFUS (203 Czech Republic), Petr NĚMEC (203 Czech Republic, belonging to the institution) and Jan VOJACEK (203 Czech Republic)
Edition
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, CARY, OXFORD UNIV PRESS INC, 2022, 1010-7940
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30201 Cardiac and Cardiovascular systems
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 3.400
RIV identification code
RIV/00216224:14110/22:00128254
Organization unit
Faculty of Medicine
UT WoS
000791440700001
Keywords in English
Ross operation; Pulmonary conduit; Reoperation; Reintervention
Tags
International impact, Reviewed
Změněno: 25/1/2023 09:08, Mgr. Tereza Miškechová
Abstract
V originále
We read the letter to the editor written by Chen et al. regarding our published study with great interest. We agree that the reintervention rate on both valves is of utmost importance. Therefore, we described the need for reintervention separately as follows: 9 patients (3.1%) in the Ross group had to undergo a reoperation due to autograft failure and 4 patients (1.4%) underwent a reoperation of the homograft. On the other hand, 16 patients (5.5%) underwent reoperation in the mechanical aortic valve replacement (mAVR) group. We conclude that there is no significant difference in the risk of reoperation between the Ross operation (RO) and mAVR (P = 0.54) in the mid-term postoperatively. However, only a limited number of patients in our study with a follow-up >10 years after the RO. Therefore, our ability to objectively analyse this long-term complication was limited.